C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids

More topics under "C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids" (173,078)
C07H 1 - Processes for the preparation of sugar derivatives (12,374)
C07H 11 - Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof (1,722)
C07H 13 - Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids (4,753)
C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975)
C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681)
C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
C07H 23 - Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin b12 (1,716)
C07H 3 - Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms (5,762)
C07H 5 - Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium (3,671)
C07H 7 - Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond (2,294)
C07H 9 - Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical (1,178)
C07H 99 - Subject matter not provided for in other groups of this subclass (52)

Patents for C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids (1,168)
10/2004
10/13/2004	EP1055682B1 Novel substances kf-1040 and process for producing the same
10/07/2004	US20040198971 Multisignal labeling reagents, and processes and uses therefor
10/03/2004	CA2461445A1 Multisignal labeling reagents, and processes and uses therefor
09/2004
09/15/2004	CN1166597C Nitrogenous group conversion method
09/02/2004	US20040171566 in a formulation suitable for intranasal, intrapulmonary or intratracheal administration; treating inflammatory diseases, particularly rheumatoid arthritis and asthma
09/01/2004	EP1451203A1 3-beta-d-ribofuranosylthiazolo(4,5-delta)pyridimine nucleosides and uses thereof
08/2004
08/26/2004	US20040167091 Methods for treating ocular neovascular diseases
08/17/2004	US6777543 13-methyl erythromycin derivatives
08/17/2004	US6777395 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virus
08/12/2004	WO2004067542A1 Oligosaccharide derivative
08/12/2004	US20040158081 Continuous process for the preparation of fructopyranose sulfamate derivatives
08/12/2004	CA2514931A1 Oligosaccharide derivative
08/11/2004	EP1444244A1 Method for the production of desclarithromycin, and intermediate products
08/10/2004	CA2130124C Anomeric fluororibosyl amines
08/04/2004	EP1441743A2 Methods for treating ocular neovascular diseases
07/2004
07/29/2004	WO2004063210A1 Novel anticonvulsant derivative salts
07/29/2004	WO2004063209A2 Methods of producing c-aryl glucoside sglt2 inhibitors
07/29/2004	CA2512389A1 Methods of producing c-aryl glucoside sglt2 inhibitors
07/29/2004	CA2511682A1 Novel anticonvulsant derivative salts
07/28/2004	EP1030673B1 Use of ketolides for preventing arterial thrombotic complications related to atherosclerosis
07/27/2004	CA2331261C 2"-deoxy hygromycin derivatives
07/21/2004	EP1438965A1 Use of extracts from Hoodia gordonii and Hoodia lugardii for the preparation of a medicament for use in the suppression of appetite
07/15/2004	US20040138439 Methods of producing C-aryl glucoside SGLT2 inhibitors
06/2004
06/24/2004	WO2004052899A2 Process for the production of 2'-branched nucleosides
06/24/2004	US20040121979 Pharmaceutically active uridine esters
06/16/2004	CN1505636A Pharmaceutically active uridine esters
05/2004
05/27/2004	WO2004044140A2 2’-substituted oligomeric compounds and compositions for use in gene modulations
05/27/2004	WO2004043978A2 2'-methoxy substituted oligomeric compounds and compositions for use in gene modulations
05/27/2004	WO2004043977A2 2’-fluoro substituted oligomeric compounds and compositions for use in gene modulations
05/27/2004	US20040102414 Methods and compositions for treating flaviviruses and pestiviruses
05/27/2004	CA2504554A1 2'-substituted oligomeric compounds and compositions for use in gene modulations
05/21/2004	WO2004041836A1 Continuous process for the preparation of fructopyranose sulfamate derivatives
05/21/2004	CA2504039A1 Continuous process for the preparation of fructopyranose sulfamate derivatives
05/20/2004	US20040097462 Methods and compositions for treating flaviviruses and pestiviruses
05/19/2004	CN1498221A Nucleoside derivatives as inhibitors of RNA-dependent PNA viral polymerase
05/13/2004	WO2003077830A3 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives
05/12/2004	EP1416941A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate
05/11/2004	CA2222581C Oligonucleotide tags for sorting and identification
04/2004
04/22/2004	WO2004033471A2 Glucose transport mutants for production of biomaterial
04/22/2004	CA2500741A1 Glucose transport mutants for production of biomaterial
04/21/2004	CN1146668C Oligonucleotide tags for sorting and identification
04/15/2004	US20040072788 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
04/15/2004	US20040072188 Comprises nucleotide sequences coding B-cell activating factor receptor (BAFF-R) for diagnosis, prevention, treatment and/or delay of cancers, lymphomas and autoimmune diseases
04/14/2004	EP1407044A2 Rna interference mediating small rna molecules
04/08/2004	US20040067901 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
04/07/2004	EP1150991B1 Compositions for treating inflammatory response
04/07/2004	CN1144809C Method for preparing aloin by extraction
04/01/2004	US20040063622 Methods and compositions for treating flaviviruses and pestiviruses
03/2004
03/31/2004	EP1402024A2 Templated molecules and methods for using such molecules
03/09/2004	CA2315796C Novel substances kf-1040 and process for producing the same
03/03/2004	CN1140535C Halo derivatives of 9-deoxo-9a-aza-9a-homery theromycin A.
02/2004
02/25/2004	EP1390378A1 Pharmaceutically active uridine esters
02/17/2004	CA2075288C Anthracycline-conjugates
02/12/2004	WO2003039404A3 Methods for treating ocular neovascular diseases
02/04/2004	EP1385857A1 Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
02/04/2004	CN1137136C Targeted cytotoxic anthracycline analogs
01/2004
01/28/2004	EP1384710A1 Synthesis of heterocyclic compounds containing five- or six-membered rings
01/22/2004	US20040014951 Isostructural pseudopolymorphs of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A
01/14/2004	CN1468249A Methods and compositions for treating flaviviruses and pestiviruses
01/08/2004	WO2003078625A3 An improved method for synthesising templated molecules
12/2003
12/30/2003	CA2076063C Sulfated glycosaminoglycanoid derivatives
12/18/2003	US20030232074 For stimulating immune activation; for screening immunostimulatory compounds
12/11/2003	US20030229031 13-Methyl erythromycin derivatives
12/03/2003	EP1075483B1 Hygromycin a derivatives
11/2003
11/27/2003	WO2002103008A3 Templated molecules and methods for using such molecules
11/20/2003	US20030216555 Processes for preparing clarithromycin polymorphs
10/2003
10/30/2003	WO2003059923A3 Methods and compositions for generating a genetically modified animal using lentiviral vectors
10/30/2003	WO2001090118A3 Haplotypes of the edn2 gene
10/29/2003	EP1355916A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
10/23/2003	WO2003086280A2 Immunostimulatory g,u-containing oligoribonucleotides
10/23/2003	WO2002103060A3 Enterovirus nucleic acids and methods for detecting enterovirus
10/23/2003	WO2002044321A3 Rna interference mediating small rna molecules
10/23/2003	US20030199461 3-beta-D-ribofuranosylthiazolo[4-5-d]pyridimine nucleosides and uses thereof
10/23/2003	CA2480775A1 Immunostimulatory g,u-containing oligoribonucleotides
10/22/2003	CN1450903A Processes for preparing clarithromycin polymorphs
10/15/2003	EP1352063A2 Receptor nucleic acids and polypeptides
10/14/2003	CA2114838C A process for making morphine-6-glucuronide or substituted morphine-6-glucuronide
10/07/2003	CA1341443C Human c3b/c4b receptor (cr1) (the)
10/01/2003	EP0863917B1 Targeted cytotoxic anthracycline analogs
09/2003
09/25/2003	WO2003078625A2 An improved method for synthesising templated molecules
09/25/2003	WO2003077830A2 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives
09/25/2003	CA2518626A1 An improved method for synthesising templated molecules
09/25/2003	CA2479211A1 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives
09/23/2003	US6624292 Methylation of erythromycin A followed by slurrying with water
09/18/2003	US20030176362 For therapy of epilepsy
09/17/2003	CN1443192A Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
09/12/2003	WO2002057414A9 Leukocyte expression profiling
09/11/2003	US20030171320 Methods for treating ocular neovascular diseases
09/04/2003	US20030167500 Methods and compositions for generating a genetically modified animal using lentiviral vectors
09/03/2003	CN1439646A Method for segregating nucleic acid
08/2003
08/28/2003	US20030162749 Use of cdp-choline for the treatment of alcohol withdrawal syndrome
08/14/2003	WO2001090115A3 Haplotypes of the cdk4 gene
08/13/2003	EP1334113A2 Leukocyte expression profiling
08/06/2003	EP1090022B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
08/06/2003	EP0994890B1 Benzimidazole derivatives
08/06/2003	CN1434830A 2-aminocarbonyl-9H-punine derivatives
07/2003
07/31/2003	WO2002024909A3 Receptor nucleic acids and polypeptides
07/24/2003	WO2003059923A2 Methods and compositions for generating a genetically modified animal using lentiviral vectors
07/24/2003	CA2470527A1 Methods and compositions for generating a genetically modified animal using lentiviral vectors
07/17/2003	US20030135038 Magnetic pigment

1 2 3 4 5 6 7 8 9 10 11 12